Background illustration for clinical trials search

Paid Clinical Trials Aurora

Discover 1,584 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,584

Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression

for

Graft Versus Host Disease

Location: Denver CO

Sponsor: Colorado Blood Cancer Institute

Sex: All

Age: 18 - 70+

Code: NCT02178683

Phase3, Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for

Myelofibrosis

Location: Denver CO, Salt Lake City UT, Tucson AZ, Minneapolis MN,

Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

for

Small Cell Lung Cancer Extensive Stage

Location: Lone Tree CO, Dallas TX, Tyler TX, St Louis MO,

Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT05703971

Phase1, Phase2, Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

for

Acute Respiratory Distress Syndrome (ARDS), ARDS,

Location: Denver CO, Murray UT, Oklahoma City OK, Fort Worth TX,

Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701656

Phase2, Recruiting

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

for

Waldenstrom Macroglobulinemia

Location: Denver CO, Dallas TX, Boston MA

Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06561347

Phase2, Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma

Location: Denver CO, St Louis MO, San Antonio TX, Duarte CA,

Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for

Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)

Location: Denver CO, Dallas TX, Iowa City IA, Madison WI,

Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase2, Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

for

Metastatic Uveal Melanoma, Cutaneous Melanoma,

Location: Denver CO, Los Angeles CA, Houston TX, Nashville TN,

Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT03947385

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for

Advanced Cancer, Advanced Solid Tumors

Location: Denver CO, Nashville TN, New Orleans LA, Orlando FL

Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase1, Phase2, Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for

Solid Tumor Malignancies

Location: Denver CO, Salt Lake City UT, Irving TX, Austin TX,

Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase1, Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for

Myeloproliferative Neoplasms

Location: Denver CO, Salt Lake City UT, Phoenix AZ, Dallas TX,

Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase1, Recruiting

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

for

Autism Spectrum Disorder, Sleep Disorder, Neurological Disorder,

Location: Boulder CO, Santa Monica CA, San Jose CA,

Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 2 - 65

Code: NCT05361707

Phase3, Recruiting

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

for

Pancreatic Cancer

Location: Denver CO, Dallas TX, San Diego CA, Louisville KY,

Sponsor: University of Louisville

Sex: All

Age: 18+

Code: NCT02674100

Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for

Head and Neck Squamous Cell Carcinoma HNSCC,

Location: Denver CO, Austin TX, San Antonio TX, San Diego CA,

Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase1, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for

Chronic Lymphocytic Leukemia (CLL),

Location: Denver CO, Salt Lake City UT, Phoenix AZ, Iowa City IA,

Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for

Multiple Myeloma

Location: Denver CO, Salt Lake City UT, Kansas City KS,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

Study of APVO436 in Patients With AML or MDS

for

AML, MDS

Location: Denver CO, Salt Lake City UT, Westwood KS, Dallas TX,

Sponsor: Aptevo Research and Development LLC

Sex: All

Age: 18+

Code: NCT03647800

Phase1, Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for

Polycythemia Vera (PV), Myelofibrosis (MF),

Location: Denver CO, Houston TX, Nashville TN, Grand Rapids MI,

Sponsor: Prelude Therapeutics

Sex: All

Age: 18+

Code: NCT07469891

Phase1, Recruiting

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for

Relapsed or Refractory Large B-cell Lymphoma

Location: Denver CO, Goodyear AZ, Austin TX, St Louis MO,

Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT07479797

Phase3, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for

Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,

Location: Denver CO, Scottsdale AZ, Dallas TX, Rochester MN,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase1, Recruiting

Paid Clinical Trials Aurora

Filter results

Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Interested in new trials?

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Study of APVO436 in Patients With AML or MDS

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers